Clinical Trials Directory

Trials / Completed

CompletedNCT01260168

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Status
Completed
Phase
Study type
Observational
Enrollment
435 (actual)
Sponsor
Exact Sciences Corporation · Industry
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer. Another objective is to provide anonymous, clinically characterized specimens for a bio-repository for future colorectal cancer-related test development.

Detailed description

Patients who have been recently diagnosed with colo-rectal cancer or pre-cancer will be asked to submit a stool sample(s)(at least 7 days AFTER colonoscopy) and will have the option of submitting blood and tissue samples for future colo-rectal cancer-related test development.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2010-12-15
Last updated
2015-05-13

Locations

21 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01260168. Inclusion in this directory is not an endorsement.